Sonoma Pharmaceuticals, Inc.【SNOA】 利益剰余金の推移

(単位:千ドル) 利益剰余金 前年比(%)
3Q25 -197,030 +1.9%
2Q25 -196,102 +1.9%
1Q25 -195,492 +2.4%
4Q24 -194,349 +2.6%
3Q24 -193,282 +2.7%
2Q24 -192,416 +3.3%
1Q24 -190,932 +3.1%
4Q23 -189,514 +2.8%
3Q23 -188,206 +3.7%
2Q23 -186,267 +3.2%
1Q23 -185,250 +2.7%
4Q22 -184,363 +2.8%
3Q22 -181,419 +5.1%
2Q22 -180,475 +5.0%
1Q22 -180,375 +5.3%
4Q21 -179,277 +4.1%
3Q21 -172,536 +1.0%
2Q21 -171,886 +1.2%
1Q21 -171,253 +1.6%
4Q20 -172,246 +1.8%
3Q20 -170,869 +2.9%
2Q20 -169,785 +3.7%
1Q20 -168,582 +4.8%
4Q19 -169,238 +7.5%
3Q19 -166,016 +8.7%
2Q19 -163,718 +9.5%
1Q19 -160,898 +9.7%
4Q18 -157,440 +10.0%
3Q18 -152,677 +8.5%
2Q18 -149,490 -4.7%
1Q18 -146,620 -5.4%
4Q17 -143,101 -6.1%
3Q17 -140,665 -5.9%
2Q17 -156,892 +7.2%
1Q17 -154,943 +7.2%
4Q16 -152,375 +7.1%
3Q16 -149,465 +6.2%
2Q16 -146,316 +8.5%
1Q16 -144,553 +7.8%
4Q15 -142,213 +6.1%
3Q15 -140,712 -0.5%
2Q15 -134,798 -4.3%
1Q15 -134,080 -3.9%
4Q14 -134,010 -2.7%
3Q14 -141,467 +4.6%
2Q14 -140,856 +5.6%
1Q14 -139,457 -
4Q13 -137,745 +4.1%
3Q13 -135,300 +3.6%
2Q13 -133,388 -
4Q12 -132,314 -
3Q12 -130,546 -